Pharmanet Logo
  • Contact Us
  • |
  • RFP
  • | 
  • Media Center
  • |
  • Study Participants
  • |
  • Investigators
  • |
  • Français
  • |
    • Overview
    • History
    • Leadership Team
    • Executive Committee
    • Corporate Responsibility
    • Overview
    • Phase I-IIa
      • First-in-Man
        • Diverse Experience
        • Modern Facilities
        • Project Management
        • Rapid Recruitment
      • Proof-of-Concept
      • Bioavailability / Bioequivalence / Biosimilars
      • Drug Drug Interaction
      • QT/TQT Capabilities
      • Special Populations
    • Bioanalytical
      • Non-GLP Analysis
      • Method Development & Validation
      • Biomarkers
      • Large Molecule Analysis
      • Clinical Lab
      • Assay List
      • Instrumentation
    • Phase IIb-III
      • Biostatistics
      • Clinical Monitoring
      • Data Management
      • Feasibility Studies
      • Global Safety and Pharmacovigilance
      • Interactive Response Technologies (IRT)
      • Investigator Recruitment and Site Management
      • Medical and Scientific Affairs
      • Medical Writing
      • Project Management
      • Protocol/Case Report Form Design
      • Patient Recruitment Services
        • Program Branding and Communications
        • Advertising and Promotion
        • Referral Network Management
    • Phase IV
      • Observational Research and Patient Registries
      • Interventional IIIB/IV Studies
      • Health Economics and Outcomes Research
      • Risk Management and Epidemiology
    • Quality Assurance
    • Consulting
      • 505(b)(2)
      • Biostatistics
      • Business Plan Services
      • Chemistry, Manufacturing, and Controls (CMC)
      • Clinical and Product Development
      • Global Safety and Pharmacovigilance
      • Life Sciences Investments
      • Pharmacokinetics and Pharmacodynamics (PK/PD)
      • Regulatory Services
      • Regulatory Liaison
    • Staffing
      • Client Services
    • Therapeutic Overview
    • Clinical Development Expertise
      • Biosimilars
      • Cell, Gene, and Tissue Therapies
      • Combination Products
      • Drug-Delivery Systems
      • Generics
      • Pediatrics
      • Small Molecule Therapeutics
      • Therapeutic Proteins
    • Therapeutic Indications
      • Cardiovascular
      • Dermatology
      • Infectious Diseases/Vaccines
      • Nephrology
      • Neuroscience
      • Oncology
      • Ophthalmology
      • Pain
      • Rheumatology
      • Women’s Health
    • Overview
    • Articles
    • Brochures
    • Case Studies
    • Fact Sheets
    • PharmaNet Publications
    • Posters
    • Presentations
    • Videos/Podcasts/Webinars
    • White Papers
    • Overview
    • FAQ
    • Job Opportunities
    • Training Programs
    • Alumni Club
    • Flexible Staffing

Services Highlights

PharmaNet, a leading global supplier of drug development services offers comprehensive capabilities and expertise in:

  • Phase I-IIa clinical trials
  • Phase IIb-III clinical trials
  • Phase IV clinical trials
  • Bioanalytical services
  • Pharmaceutical and regulatory consulting
  • Flexible staffing
  • Therapeutic solutions

For a clinical research organization with the applied knowledge and intelligent solutions needed to accelerate quality drug development programs anywhere in the world, PharmaNet works for you.

Learn More 

News

1.24.12 | PharmaNet/i3 Announces the Opening of the 6th Edition of the Survey on Observational Research
12.01.11 | PharmaNet/i3 CEO Jeff McMullen Elected 2012 ACRO Chairman
    More News 

Blog

Pharmacovigilance = (Effective + Safety) Therapeutics

The Advent of Mobile IRT Solutions in Clinical Trials

Principles in Quality Assurance: The "Grip/Build/Engage (GBE) Model

Comparative Effectiveness Research - What's Old is New Again

More

Events

02.15.12   | Outsourcing in Clinical Trials West Coast
02.28.12   | World Generic Medicines Congress
03.05.12   | Partnerships in Clinical Trials 2012
    More Events 
  • Dalvir Gill Talks About PharmaNet's Future
  • Solutions for Biologic Dev
  • Overcome LC/MS/MS Challenges
  • Adaptive Trial Designs in Oncology
Physician Payment Sunshine Act Inquiries
  • PharmaNet Development Group, Inc, 504 Carnegie Center, Princeton, NJ 08540 USA
  • |
  • Phone: +1-609-951-6800
  • |
  • Email: pni@pharmanet.com
  • |
  • Site Map
  • |
  • Privacy Policy
  • |
  • Terms & Conditions